GENNEX LABORATORIES
Back to Balance Sheet
|
GENNEX LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹14 Cr | ₹18 Cr | ₹9.42 Cr | ₹11 Cr | ₹7.66 Cr |
What is the latest Sundry Debtors ratio of GENNEX LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹14 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹9.42 Cr |
| Mar2022 | ₹11 Cr |
| Mar2021 | ₹7.66 Cr |
How is Sundry Debtors of GENNEX LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹14 Cr | -20.49 | |
| Mar2024 | ₹18 Cr | 89.14 | |
| Mar2023 | ₹9.42 Cr | -16.76 | |
| Mar2022 | ₹11 Cr | 47.75 | |
| Mar2021 | ₹7.66 Cr | - | |
Compare Sundry Debtors of peers of GENNEX LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENNEX LABORATORIES | ₹250.4 Cr | -0.1% | 20.6% | -20.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,859.0 Cr | 4.2% | 5.3% | 1.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹176,618.0 Cr | 3.4% | 12.6% | 8.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹144,718.0 Cr | 2.2% | 4.1% | 28% | Stock Analytics | |
| CIPLA | ₹107,722.0 Cr | 2% | 11.5% | -13.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,081.0 Cr | -6.2% | 5.1% | 9.5% | Stock Analytics | |
GENNEX LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENNEX LABORATORIES | -0.1% |
20.6% |
-20.8% |
| SENSEX | -0.4% |
7.1% |
-4% |
You may also like the below Video Courses